Rat vHL(Von Hippel Lindau Tumor Suppressor) ELISA Kit

3h

tumor

20ng/mL

Sandwich

0.113ng/mL

0.312-20ng/mL

Tumor immunity;

Rattus norvegicus

HRCA1; RCA1; VHL1; Von Hippel-Lindau Syndrome

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays

Kinase, breast cancer tumor, HRAS like - suppressor protein make genetic suppression restoring the phenotype seen prior to the original background in biological pathways.

Rats are used to make rat monoclonal anti mouse antibodies. There are less rat- than mouse clones however. Rats genes from rodents of the genus Rattus norvegicus are often studied in vivo as a model of human genes in Sprague-Dawley or Wistar rats.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Von Hippel Lindau Tumor Suppressor (vHL). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Von Hippel Lindau Tumor Suppressor (vHL). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Von Hippel Lindau Tumor Suppressor (vHL), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Von Hippel Lindau Tumor Suppressor (vHL) in the samples is then determined by comparing the O.D. of the samples to the standard curve.